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Abstract	
Background	
Cross-sectional studies report a relationship between childhood asthma and ADHD 
symptoms, but the mechanisms are yet unclear. Our objective was to investigate the 
longitudinal link between childhood asthma and the two dimensions of ADHD (hyperactivity-
impulsivity, HI and inattention, IN) in adolescence. We also aimed to explore the genetic and 
environmental contribution and the impact of asthma medication. 
Methods	
Data on asthma, HI and IN, birth weight, socioeconomic status, zygosity and medication was 
collected from the Swedish Medical Birth Register and through parental questionnaires at 
ages 8-9 and 13-14 years on 1,480 Swedish twin pairs born 1985-86. The association between 
asthma at age 8-9 and ADHD symptoms at age 13-14 was assessed with generalized 
estimating equations, and twin analyses to assess the genetic or environmental determinants 
were performed.  
Results	
Children with asthma at age 8-9 had an almost twofold increased risk of having one or more 
symptom of HI (OR 1.88, 95% CI 1.18-3.00) and a more than two-fold increased risk to have 
three symptoms or more of HI (OR 2.73, 95% CI 1.49-5.00) at age 13-14, independent of 
asthma medication. For IN, no significant relationship was seen. Results from twin modeling 
indicate that 68% of the phenotypic correlation between asthma and HI (r=0.23, 0.04-0.37) 
was due to genetic influences.  
Conclusions	
Our findings suggest that childhood asthma is associated with subsequent development of HI 
in early adolescence, which could be partly explained by genetic influences. Early strategies 
to identify children at risk may reduce burden of the disease in adolescence. 
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Introduction	
Asthma and attention-deficit/hyperactivity disorder (ADHD) are both common chronic 
disorders affecting children. Asthma is characterized by wheezing, breathlessness and chest 
tightness affecting about 6-8% in childhood and adolescence (1). ADHD is characterized, 
according to DSM-IV by hyperactivity-impulsivity (HI) and inattention (IN) with a 
prevalence of 3-5% in school-aged children (2). Several previous studies, including a meta-
analysis (3), have shown an association between asthma and ADHD symptoms (4-6), though 
studies do exist where a relationship was not found (7, 8). One study of 102,253 children from 
the National Survey of Children’s Health showed a two-fold increased prevalence of ADHD 
among children with asthma, and even higher rates of ADHD among children with severe 
asthma (9). Similar dose-response effects have been observed in relation to broad assessments 
of behavioral problems (10, 11).  
The nature of the relationship between asthma and ADHD is not entirely clear. None of the 
previous studies have distinguished between the two DSM-IV ADHD symptom dimensions, 
which is a critical issue as HI and IN have partly distinct etiologies (12) and developmental 
outcomes (13). All of the prior asthma-ADHD association studies have been cross-sectional, 
which constrains possibilities to study the direction of effect and the developmental link 
between the two conditions. In addition, possible mechanisms underlying this association 
remain to be investigated.   
Firstly, the association between asthma and ADHD could be due to shared risk factors. Low 
birth weight, impaired fetal growth and low socioeconomic status are known risk factors for 
asthma (14, 15) and ADHD (16, 17). None of the previous studies on the asthma-ADHD 
association have adjusted for birth weight, while most studies have adjusted for gender and 
different measures of socioeconomic status (5, 9, 10) with remaining stable estimates. 
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 Secondly, the link asthma-ADHD may be due to asthma medication such as inhaled 
corticosteroids (ICS). There have been case reports of altered behavior and psychosis in small 
children using ICS (18), but larger studies suggest no evidence of major adverse 
neuropsychiatric effects (19). One study was able to show higher rates of hyperactivity in 
children with asthma compared to healthy controls; however the rates were similar to other 
children under specialist care for non-respiratory complaints, indicating that ICS does not 
affect behavior (20).  
Thirdly, shared genetic factors could account for the observed association between asthma 
and ADHD. However, although twin studies consistently have shown that asthma and ADHD 
are heritable disorders (12, 21) examinations of genetic and shared contributions to the 
overlap between the two conditions is still lacking. Two previous family-based studies have 
examined the potential impact of familial effects for the association, but failed to find support 
for such a conclusion (8, 22). Clearly, additional research is needed to clarify this issue.  
Our overall aim was to study the longitudinal relationship between childhood asthma and 
ADHD in adolescence, including genetic and other confounding factors and the impact of 
asthma medication in a prospective study of 1,480 twin pairs followed from 8-9 to 13-14 
years of age. We used a quantitative measure of ADHD to assess DSM-IV symptoms of 
hyperactivity-impulsivity and inattention, since sophisticated statistical modeling techniques 
have been used to show that ADHD exists on a severity continuum (23).   
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Methods 
Study design and population  
The Twin study of CHild and Adolescent Development (TCHAD) is a longitudinal study 
from childhood onwards. Study population and data collection has been described elsewhere 
(24). Data was collected by parental questionnaires when twins born between May 1985 and 
December 1986 were 8-9 (wave 1, response rate 74.9 %) and 13-14 (wave 2) years old, 
Figure 1. The waves were separate, so that non-responders from wave 1 were still eligible for 
participation at age 13-14.   
Variables  
Asthma was measured as a main outcome by using the standardized question in the 
International study of Asthma and Allergies in Childhood (ISAAC) study “Has your child 
ever had asthma” (yes/no). If “yes”, follow-up questions regarding age of onset and number 
of asthma episodes in the previous year were asked. Eczema was measured by the 
standardized question “Has your child ever had eczema” (yes/no). 
Parents provided ratings of ADHD symptoms in their children via a checklist of 14 DSM-IV 
based items (2) and were asked to check symptoms persisting for at least six months (0/1). A 
hyperactivity-impulsivity scale was created from the sum of 8 symptoms of hyperactivity-
impulsivity listed in DSM-IV and an inattention scale from the sum of 6 items related to 
inattention. There are strong arguments for considering ADHD as an extreme of a 
dimensional trait (23) so cutoffs were imposed to create multiple dichotomized variables that 
identify individuals with; a) one or more HI/IN symptoms (HI-1 and IN-1), b) two or more 
HI/IN symptoms (HI-2 and IN-2); and so on until f) six or more HI/IN symptoms (HI-6 and 
IN-6) (12, 25).  
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Birth weight data was obtained by linking data from TCHAD to the Swedish Medical Birth 
Register as previously described (16) and categorized into 500 gram intervals.  
Socioeconomic status was classified according to the Nordic standard occupational 
classification and Swedish socio-economic classification (SEI) (26).  
Medication was assessed in the questionnaire with the question ”does this child use 
medication on a regular basis”. All individuals with reported ICS and/or inhaled β2-agonist 
were considered using asthma medication. The questions on zygosity have been validated 
with DNA markers in previous studies and proved correct in 95% (24). 
Statistical analysis 
Odds ratio (OR) with 95% confidence intervals (CI) for the associations between asthma, HI 
and IN were estimated using the logit link in generalized estimating equations (GEE), which 
allow us to account for the dependent nature of the twin observations. The longitudinal 
analyses were exploratory and involved a series of regression models with the multiple 
dichotomized variables of HI or IN at age 13-14 as outcome variables and asthma at age 8-9 
as a predictor. The models were applied with and without controlling for well established 
covariates, including sex, socioeconomic status, birth weight and eczema. We also added 
ADHD symptoms at age 8-9 into the model, to estimate the effect of asthma at age 8/9 on 
increasing HI/IN symptoms between age 8/9 and 13/14. Only data from children with 
complete answers on asthma, HI and IN were used in the fully adjusted model. 
All the statistical analyses were performed in the SAS 9.1.3 using GENMOD procedure (SAS 
Institute, Inc., Cary, NC.). 
Twin methods were used to examine how genetic and environmental factors contribute to the 
association between asthma and ADHD.  
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Basically, we fitted a bivariate liability threshold model in MX (27), to estimate the additive 
genetic (A), shared environmental (C)and non-shared environmental (E) contributions to the 
overlap in liability between asthma and ADHD. The model also estimates the genetic, shared 
and non-shared environmental correlations. This statistic varies from -1.0 to +1.0 and 
indicates the extent to which genetic and environmental influences in one measure overlap 
with those on a second measure and the genetic, shared and non-shared environmental 
contribution to the phenotypic correlation between two traits is obtained. 
Permission for the study was obtained from the Regional Ethical Review board in Stockholm, 
Sweden. 
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Results	
The total study population consisted of all 1,812 responders with data on asthma and ADHD 
symptoms either at age 8-9, age 13-14 or both (Figure 1). In total, 2,134 children had 
complete answers on asthma and symptoms of ADHD (HI and IN) at age 8-9, 1,883 children 
had complete answers at age 13-14 and 1,754 children had complete answers at both ages. 
Table 1 shows rates of asthma HI-3 and IN-3 by background characteristics. Boys showed 
higher rates of asthma and IN-3. Socioeconomic status was significantly associated with HI 
and IN at age 8-9 and age 13-14, and birth weight was significantly associated with HI at age 
8-9. Almost identical results were observed for all other levels of HI and IN (e.g. HI-4, HI-5, 
HI-6), data not shown.  
In the cross-sectional analyses on the association between asthma and ADHD (HI and IN), the 
prevalence of twins with asthma increased in the higher categories of HI and IN at both age 8-
9 and 13-14. The increase was continuous throughout the categories, although not significant 
at all levels (Table 2).  
In the longitudinal analyses, children with asthma at age 8-9 were more likely to have parent-
reported symptoms of HI at age 13-14 (Table 3) and more than two-fold increased risk of HI-
3 at age 13-14 (OR 2.50, 95% CI 1.46-4.28) in the unadjusted models. The results were stable 
after adjusting for sex, birth weight and socioeconomic status. Results also remained at same 
level after adjustment for previous HI and IN symptoms (OR 2.73, 95% CI 1.49-5.00), 
suggesting an effect of asthma on change in ADHD symptoms. In stratified analyses of 
children without early symptoms of ADHD, OR remained stable. The association between 
asthma and HI did not change with adjustment for eczema (Table 3). 
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Asthma at age 8-9 was also associated with a significantly increased risk of IN 4-6 (ranging 
from OR 2.77, 95% CI 1.23-6.26 to OR 8.36, 95% CI 1.52-45.81). However, none of these 
associations were significant in the adjusted model. 
Fifty-eight (44.6%) of the 130 asthmatic children with information regarding asthma 
medication at age 8-9 were using asthma medication on a regular basis at age 8-9, and fifty 
(35.5%) out of 141 at age 13-14. There was no significant difference in HI between asthmatic 
children with or without asthma medication. 
Twin analyses were limited to HI-3, because higher cut-off values (i.e., HI-4, HI-5, HI-6) 
resulted in cells with few of zero participants. Table 4 shows intra-class and cross-trait cross-
twin (CTCT; the correlation between twin1’s status on asthma and the co-twin’s status on HI) 
correlations for asthma at age 8-9 and HI-3 at age 13-14, by zygosity. MZ intra-class and 
CTCT correlations were consistently higher than the corresponding DZ correlations, 
suggesting substantial genetic influences on HI-3, asthma as well as on the overlap between 
the phenotypes. Bivariate liability threshold modelling suggest that the variance in liability of 
asthma was explained by genetic (74%; 95% CI: 0.69-0.86) and non-shared environmental 
influences (26%; 0.14-0.33) influences. The variance in liability of HI-3 was explained by 
genetic (76%; 0.58-0.88) and non-shared environmental (24%; 0.12-0.42) influences. The 
genetic and non-shared environmental correlations between asthma and HI-3 were estimated 
as 0.21 (0.00-0.51) and 0.29 (0.00-0.64), respectively. Calculations of the genetic and non-
shared environmental contribution to the phenotypic correlation revealed that 68% of the 
phenotypic correlation between asthma and HI-3 (r = 0.23, 0.04-0.37) was due to genetic 
influences. 
 11 
 
Discussion	
We found that children with asthma at age 8-9 had an almost twofold increased risk of parent-
reported HI at age 13-14, compared with children without asthma. The association was 
consistent also after adjustment for potential confounders. Results from the twin analyses 
indicate that the association between asthma and HI could be in part due to genetic influences. 
Thus our results, based on the first twin study on the longitudinal association between asthma 
and ADHD, support the hypothesis that there is a genetic overlap between asthma and HI 
phenotypes. 
Previous studies have shown a cross-sectional association between asthma and ADHD or HI 
(5, 6, 9, 20). Important strengths of the current study are that the relationship between asthma 
and ADHD symptoms was examined prospectively over time, and that the two ADHD 
dimensions were assessed separately (13). Our study shows that childhood asthma predicts HI 
in adolescence but not IN, which provide further support for the distinction between the two 
symptom dimensions of ADHD. In line with the dimensional model of ADHD (23, 28, 29), 
the prospective asthma-HI link was observed across the range of severity in HI symptoms, 
and an almost linear increase in risk was seen for each additional HI symptom, which 
highlight the need for studies that evaluate how asthma is involved in the transition from 
milder to more severe levels of ADHD symptoms. 
The association between parent-reported asthma and HI was stable for sex, birth weight and 
socioeconomic status. We saw an effect of low birth weight and socioeconomic status on 
ADHD symptoms at age 8-9 which was expected (16, 17), however birth weight and 
socioeconomic status had no effect of on asthma, in contrast to previous studies (14, 15). 
Recent studies have shown a relationship between ADHD, atopic eczema and sleeping 
problems (30, 31). We did not find any differences in the association between asthma and 
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symptoms of hyperactivity-impulsivity when adjusting for eczema. Our confounding 
measures of socioeconomic status, birth weight and eczema may not be strong enough to 
detect confounding, which could result in an overestimation of the association between 
asthma and ADHD symptoms. Moreover, our study did not show any significant differences 
regarding asthma medication and level of HI, which highlights the need of future studies (20). 
The results from the twin analysis extends previous research by showing that the association 
between asthma and HI symptoms is partly influenced by genetic effects. However, despite 
the large sample, extreme levels of HI/IN and new cases of asthma were rare at age 13-14, 
which constrains the power of the twin analysis. It should also be noted that our results are 
inconsistent with two previous family-based studies (8, 22) that failed to identify a familial 
component underlying the asthma-ADHD association. Both previous studies were based upon 
a clinically referred sample, used DSM-III-criteria and did not distinguish between HI and IN. 
Nevertheless, our finding of a genetic overlap between asthma and HI should be considered in 
future molecular genetic investigations.  
This study should be interpreted in the context of its limitations. First, asthma and symptoms 
of ADHD were assessed using parent-report questionnaires and it is important to underline 
that this is not equivalent to a diagnosis of ADHD. Also, relying on a single source of 
informant (i.e, parent-report) to assess ADHD symptoms could be considered to be a 
limitation of our study. Second, twin studies may not be generalizable, although studies 
indicate that twins do not differ from singletons concerning risk of asthma (32) while the 
results regarding ADHD are mixed (33, 34). 
Third, although the response rate of this study was relatively high selective attrition is always 
a concern in longitudinal studies, however previous studies (25, 35) have suggested that bias 
due to selective attrition is limited.   
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Fourth, we did not have information on age of onset of ADHD and the possibilities to draw 
causal conclusions are constrained. For example, we cannot rule out that the observed 
association between asthma and HI may in part be explained by the presence of unmeasured 
ADHD symptoms in early childhood. In conclusion, this population-based longitudinal study 
indicates that early asthma is associated with an increased risk of elevated levels of 
hyperactivity-impulsivity later in life. These findings highlight the need for increased clinical 
attention to problems associated with ADHD symptoms in asthmatic children. Exploring the 
association between asthma and ADHD further may provide better opportunities to target 
early intervention and support to these children and their families.  
 
 14 
 
Acknowledgements 
The authors would like to gratefully acknowledge the children and parents of the TCHAD 
twin cohort, without whose participation this study would have been impossible to perform 
and Paul Lichtenstein for initiating the TCHAD twin cohort. We are also indebted to Marcus 
Boman for data management and to Dr Kirsten Holmberg for clinical comments and views. 
Financial support was provided through the regional agreement on medical training and 
clinical research (ALF) between Stockholm County Council and Karolinska Institutet, grants 
from the Swedish Research Council (SIMSAM grant number 80748301), the Centre for 
Allergy Research and the Strategic Research Program in Epidemiology at Karolinska 
Institutet. The Swedish Twin Registry is supported by grants from the Swedish Department of 
Higher Education. Henrik Larsson was funded by a post-doc stipend from the Swedish brain 
foundation and Karolinska Institutet center of neurodevelopmental disorders.  
 
 
 15 
 
Figure	1.	Study	population	and	response	rates	at	ages	8‐9	and	13‐14	in	a	cohort	of	1,812	Swedish	twins	
born	1985‐1986.	
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TABLE	1.	Study	population	characteristics,	asthma	and	ADHD	symptoms	in	a	cohort	of	1,812		Swedish	twins	born	
1985‐1986.		
 
SEI=socioeconomic status. 1) Unskilled and semi‐skilled workers 2) Skilled workers/Assistant non‐manual employees 3) 
Intermediate non‐manual collar workers 4) Employed and self‐employed professionals, higher civil servants, and executives. 
MZ=monozygotic.DZ=dizygotic
      Asthma    HI≥3    IN≥3   
  N  %  n     %  p  n  %  P  n  %  P 
Age 8‐9                       
Total  1812    104  5.7    277  15.5    137  7.7 
   Missing      ‐  ‐    25  ‐    18  ‐   
Gender                       
Male  892  49.2  66  7.4    155  18.0    86  9.8 
Female  920  50.8  38  4.1  0.0028  122  13.5  0.0159  51  5.6  0.0010
Birthweight, g                     
0‐1999  211  11.8  15  7.1    37  17.9    22  10.5 
2000‐2499  463  26.0  28  6.1    89  19.4    37  8.1 
2500‐2999  704  39.5  41  5.8  0.3564  98  14.1  0.0166  50  7.2  0.1918
3000‐3499  346  19.4  20  5.8    45  13.2    20  5.8 
≥3500  60  3.4  0  0    4  6.8    4  6.8 
Missing  28    0  0    4  14.3    4  14.3   
SEI                       
Sei1  284  16.0  16  5.6    57  20.4    32  11.5 
Sei2  498  28.0  26  5.2    88  17.8    36  7.3 
Sei3  470  26.4  28  6.0  0.9387  49  10.6  <0.0001  28  6.0  0.0003
Sei4  386  21.7  21  5.4    34  8.9    16  4.2 
Other  142  8.0  10  7.0    39  27.7    19  13.5 
Missing  32    3  9.4    10  34.5    6  20.0   
Zygosity                       
MZ  747  41.2  44  5.9    108  14.8    47  6.4   
DZ  1027  56.7  57  5.6  0.8083  165  16.2  0.8479  88  8.6  0.4406
Unknown  38  2.1  3  7.9    4  10.5    2  5.3   
                       
Age 13‐14                 
Total  1812    138  7.7    128  7.1    125  6.9 
   Missing  ‐    30  ‐    ‐  ‐    2  ‐   
Gender                       
Male  892  49.2  90  10.3    71  8.0    71    8.0   
Female  920  50.8  48  5.3  <0.0001  57  6.2  0.1429  54   5.9  0.0814
Birthweight, g                     
0‐1999  211  11.8  19  9.2    19  9.0    18  8.5   
2000‐2499  463  26.0  34  7.4    35  7.6    32  6.9   
2500‐2999  704  39.5  61  8.8  0.2394  38  5.4  0.2425  48  6.8  0.7278
3000‐3499  346  19.4  22  6.5    27  7.8    24  6.9 
≥3500  60  3.4  1  1.7    6  10.0    2  3.3 
Missing  28    1  3.6    3  10.7    1  3.6   
SEI                       
Sei1  284  16.0  22  7.9    27  9.5    28  9.9   
Sei2  498  28.0  38  7.8    41  8.2    29  5.8 
Sei3  470  26.4  34  7.3  0.7215  24  5.1  0.0003  22  4.7  0.0305
Sei4  386  21.7  29  7.4    12  3.1    25  6.5 
Other  142  8.0  15  10.9    17  12.0    14  9.9 
Missing  32    1  3.3    7  21.9    7  21.9   
Zygosity                       
MZ  747  41.2  56  7.6    45  6.0    45  6.0   
DZ  1027  56.7  76  7.5  0.1717  80  7.8  0.3510  76  7.4  0.3515
Unknown  38  2.1  6  15.8    3  7.9    4  10.5   
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TABLE	2.	Prevalence	of	Asthma	and	ADHD‐symptoms	and	odds	ratios	(OR)	for	the	association	cross	sectionally	in	a	
cohort	of	1,812	Swedish	twins	born	1985‐6.		
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N=  total amount of responders on asthma and ADHD‐questions who scored this level or higher. 
* Reference category is no ADHD symptoms. 
 
	
 
   
Responders  
 
Responders 
with Asthma 
  Association between 
ADHD‐symptoms and 
Asthma 
No of symptoms ≥               
N  %  n  %    OR*  95% CI 
               
Age 8‐9                 
  HI               
  0  2138  100.0  128  6.0       
    1  910  42.6  55  6.0    1.03  0.72‐1.47 
  2  592  27.7    42  7.1    1.31  0.89‐1.93 
  3  337  15.8  26  7.7    1.39  0.88‐2.19 
  4  200  9.4  18  9.0    1.63  0.96‐2.78 
  5  118  5.5  13  11.0    1.94  1.03‐3.66 
  6  56  2.6  7  12.5    1.89  0.77‐4.65 
                 
  IN               
  0  2145  100.0  129  6.0       
    1  839  39.1  61  7.3    1.40  0.97‐2.02 
  2  384  17.9  33  8.6    1.61  1.06‐2.45 
  3  177  8.3  19  10.7    1.81  1.05‐3.10 
  4  62  2.9  10  16.1    2.53  1.23‐5.20 
  5  21  1.0  3  14.3    1.55  0.36‐6.63 
  6  7  0.3  1  14.3    2.08  0.34‐12.61 
                 
Age 13‐14                 
  HI               
  0  1887  100.0  147  7.8       
    1  442  23.4  48  10.9    1.65  1.16‐2.37 
  2  231  12.3  24  10.4    1.36  0.86‐2.15 
  3  137  7.3  18  13.1    1.84  1.09‐3.12 
  4  78  4.1  11  14.1    1.78  0.87‐3.64 
  5  36  1.9  8  22.2    3.10  1.26‐7.61 
  6  20  1.1  5  25.0    2.88  0.80‐10.33 
                 
  IN               
  0  1886  100.0  145  7.7       
    1  655  34.7  56  8.6    1.19  0.84‐1.70 
  2  287  15.2  23  8.0    1.01  0.62‐1.65 
  3  135  7.2  14  10.4    1.37  0.76‐2.49 
  4  54  2.9  8  14.9    1.75  0.72‐4.26 
  5  21  1.1  4  19.1    1.86  0.44‐7.81 
  6  7  0.4  2  28.6    4.29  0.98‐18.75 
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TABLE	3.	Risk	of	symptoms	of	hyperactivity‐impulsivity	and	inattention	respectively	at	age	13‐14	by	asthma	at	age	8‐
9.	N=	1,812.	
* Adjusted for sex. socioeconomic status and birth weight. 
*+Adjusted as above, and for eczema ever at age 8‐9. 
** Adjusted for sex. socioeconomic status, birth weight  and for previous symptoms of inattention and hyperactivity. 
**+ Adjusted as above, and for eczema ever at age 8‐9. 
	
	
	
	
	 	 	 	
  Unadjusted                 
  OR  (95% CI)  OR *  (95% CI)  OR 
*+ 
(95% CI)  OR **  (95% CI)  OR 
**+ 
(95% CI) 
Hyperactivity                     
at age 13‐14                     
HI‐1   1.78  1.09‐2.92  1.72  1.12‐2.64  1.78  1.11‐2.86  1.88  1.18‐3.00  1.88  1.14‐3.09 
HI‐2   2.34  1.33‐4.14  1.83  1.09‐3.07  2.09  1.16‐3.77  1.80  1.04‐3.11  2.09  1.14‐3.85 
HI‐3   2.50  1.46‐4.28  2.52  1.39‐4.50  3.01  1.55‐5.84  2.73  1.49‐5.00  3.60  1.91‐6.77 
HI‐4   2.99  1.62‐5.54  3.14  1.60‐6.17  3.41  1.62‐7.19  2.80  1.30‐6.03  3.33  1.44‐7.68 
HI‐5   5.57  2.44‐12.71  5.74  2.36‐13.96  6.94  2.64‐18.25  6.83  2.69‐17.37  9.62  3.14‐29.51 
HI‐6 
  
8.92  3.17‐25.10  10.00  3.15‐31.78  NA  NA  14.32  3.48‐58.99  NA  NA 
Inattention                     
at age 13‐14                     
IN‐1  1.06  0.73‐1.55  1.01  0.70‐1.48  0.96  0.63‐1.48  0.99  0.63‐1.53  0.88  0.54‐1.43 
IN‐2  1.21  0.73‐2.00  1.17  0.69‐1.98  1.28  0.71‐2.28  1.08  0.62‐1.88  1.17  0.65‐2.09 
IN‐3  1.61  0.84‐3.08  1.59  0.82‐3.11  1.81  0.86‐3.83  1.62  0.85‐3.08  1.94  0.97‐3.90 
IN‐4  2.77  1.23‐6.26  2.59  1.13‐5.95  2.36  0.85‐6.52  2.03  0.86‐4.78  2.14  0.81‐5.64 
IN‐5  3.62  1.04‐12.57  3.48  0.93‐13.07  2.61  0.47‐14.33  2.19  0.58‐8.29  1.96  0.40‐9.66 
IN‐6  8.36  1.52‐45.81  NA  NA  NA  NA  NA  NA  NA  NA 
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TABLE	4.	Tetrachoric	correlation	matrices	estimated	from	LT	model	for	MZ	and	DZ	twins.  
   
N* 
Asthma   
age 8‐9 
HI‐3 
age 13‐14 
CTCT 
Correlation 
MZ  459  0.74 
(0.63‐0.85) 
0.76 
(0.64‐0.87) 
0.11 
(0.00‐0.38) 
DZ  650  0.41 
(0.24‐0.58) 
0.33 
(0.17‐0.48) 
0.08 
(0.00‐0.30) 
Note.	N,	number	of	twin	pairs;	MZ,	monozygotic;	DZ	dizygotic.		
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